Rhenman & Partners Asset Management AB as of March 31, 2014
Portfolio Holdings for Rhenman & Partners Asset Management AB
Rhenman & Partners Asset Management AB holds 90 positions in its portfolio as reported in the March 2014 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Gilead Sciences (GILD) | 5.3 | $18M | 249k | 70.86 | |
| Alexion Pharmaceuticals | 5.1 | $17M | 112k | 152.13 | |
| Regeneron Pharmaceuticals (REGN) | 5.0 | $17M | 56k | 300.28 | |
| Biogen Idec (BIIB) | 3.8 | $13M | 41k | 305.86 | |
| Pfizer (PFE) | 3.4 | $11M | 353k | 32.12 | |
| BioMarin Pharmaceutical (BMRN) | 3.0 | $9.9M | 145k | 68.21 | |
| Pharmacyclics | 2.9 | $9.8M | 97k | 100.22 | |
| Alkermes (ALKS) | 2.7 | $8.9M | 201k | 44.09 | |
| Celgene Corporation | 2.5 | $8.2M | 58k | 139.59 | |
| Johnson & Johnson (JNJ) | 2.0 | $6.8M | 70k | 98.24 | |
| Medivation | 2.0 | $6.7M | 105k | 64.37 | |
| CVS Caremark Corporation (CVS) | 2.0 | $6.6M | 88k | 74.86 | |
| Incyte Corporation (INCY) | 1.7 | $5.7M | 107k | 53.52 | |
| Teva Pharmaceutical Industries (TEVA) | 1.7 | $5.7M | 108k | 52.84 | |
| Salix Pharmaceuticals | 1.7 | $5.6M | 54k | 103.61 | |
| Actavis | 1.6 | $5.2M | 26k | 205.86 | |
| Cardinal Financial Corporation | 1.5 | $5.0M | 72k | 69.98 | |
| NPS Pharmaceuticals | 1.5 | $5.0M | 167k | 29.93 | |
| Keryx Biopharmaceuticals | 1.4 | $4.5M | 265k | 17.04 | |
| Forest Laboratories | 1.3 | $4.4M | 48k | 92.27 | |
| Abbvie (ABBV) | 1.3 | $4.4M | 86k | 51.40 | |
| Merck & Co (MRK) | 1.3 | $4.4M | 77k | 56.76 | |
| ACADIA Pharmaceuticals (ACAD) | 1.3 | $4.3M | 177k | 24.33 | |
| Stryker Corporation (SYK) | 1.2 | $4.2M | 51k | 81.47 | |
| Cyberonics | 1.2 | $4.2M | 64k | 65.25 | |
| Thermo Fisher Scientific (TMO) | 1.2 | $4.1M | 34k | 120.25 | |
| CIGNA Corporation | 1.2 | $4.1M | 49k | 83.73 | |
| Amgen (AMGN) | 1.2 | $4.0M | 46k | 85.62 | |
| Boston Scientific Corporation (BSX) | 1.2 | $3.9M | 285k | 13.52 | |
| Hca Holdings (HCA) | 1.1 | $3.7M | 70k | 52.50 | |
| Catamaran | 1.1 | $3.6M | 81k | 44.76 | |
| Edwards Lifesciences (EW) | 1.0 | $3.4M | 46k | 74.18 | |
| Allergan | 1.0 | $3.4M | 28k | 124.11 | |
| NuVasive | 1.0 | $3.4M | 88k | 38.41 | |
| Dex (DXCM) | 1.0 | $3.3M | 79k | 41.36 | |
| Covidien | 1.0 | $3.3M | 44k | 73.65 | |
| Bristol Myers Squibb (BMY) | 0.9 | $3.2M | 87k | 36.61 | |
| Aegerion Pharmaceuticals | 0.9 | $3.2M | 68k | 46.11 | |
| Eli Lilly & Co. (LLY) | 0.9 | $3.1M | 54k | 58.87 | |
| Centene Corporation (CNC) | 0.9 | $2.9M | 47k | 62.24 | |
| UnitedHealth (UNH) | 0.9 | $2.9M | 63k | 45.32 | |
| Express Scripts Holding | 0.8 | $2.8M | 38k | 75.09 | |
| Insulet Corporation (PODD) | 0.8 | $2.8M | 59k | 47.42 | |
| McKesson Corporation (MCK) | 0.8 | $2.8M | 27k | 104.06 | |
| Community Health Systems (CYH) | 0.8 | $2.7M | 69k | 39.16 | |
| PAREXEL International Corporation | 0.8 | $2.7M | 49k | 54.10 | |
| Ligand Pharmaceuticals In (LGND) | 0.8 | $2.7M | 40k | 67.25 | |
| Endologix | 0.8 | $2.6M | 202k | 12.87 | |
| Thoratec Corporation | 0.7 | $2.5M | 69k | 35.81 | |
| Medtronic | 0.7 | $2.4M | 39k | 61.53 | |
| Omnicare | 0.7 | $2.3M | 39k | 59.68 | |
| Abiomed | 0.7 | $2.3M | 90k | 26.04 | |
| St. Jude Medical | 0.7 | $2.2M | 34k | 65.39 | |
| Nektar Therapeutics (NKTR) | 0.7 | $2.2M | 182k | 12.12 | |
| Dynavax Technologies Corporation | 0.7 | $2.2M | 1.2M | 1.80 | |
| Rite Aid Corporation | 0.7 | $2.2M | 345k | 6.27 | |
| Orexigen Therapeutics | 0.6 | $2.1M | 329k | 6.50 | |
| WellPoint | 0.6 | $2.1M | 40k | 53.25 | |
| Varian Medical Systems | 0.6 | $2.0M | 34k | 59.88 | |
| Cepheid | 0.6 | $2.0M | 39k | 51.59 | |
| Baxter International (BAX) | 0.6 | $2.0M | 42k | 47.05 | |
| Ariad Pharmaceuticals | 0.6 | $1.9M | 238k | 8.06 | |
| Hyperion Therapeutics | 0.6 | $1.9M | 74k | 25.81 | |
| Intra Cellular Therapies (ITCI) | 0.5 | $1.8M | 98k | 18.18 | |
| Supernus Pharmaceuticals (SUPN) | 0.5 | $1.8M | 197k | 8.94 | |
| Auxilium Pharmaceuticals | 0.5 | $1.7M | 64k | 27.18 | |
| Masimo Corporation (MASI) | 0.5 | $1.7M | 64k | 27.30 | |
| AmerisourceBergen (COR) | 0.5 | $1.6M | 35k | 46.77 | |
| Endocyte | 0.5 | $1.6M | 69k | 23.81 | |
| Universal Health Services (UHS) | 0.5 | $1.6M | 20k | 82.07 | |
| Becton, Dickinson and (BDX) | 0.5 | $1.6M | 24k | 66.08 | |
| CareFusion Corporation | 0.5 | $1.6M | 39k | 40.22 | |
| Array BioPharma | 0.5 | $1.5M | 329k | 4.70 | |
| Revance Therapeutics (RVNC) | 0.5 | $1.5M | 49k | 31.51 | |
| Celldex Therapeutics | 0.4 | $1.3M | 74k | 17.67 | |
| Trovagene | 0.3 | $1.1M | 197k | 5.73 | |
| ImmunoGen | 0.3 | $1.1M | 74k | 14.92 | |
| Infinity Pharmaceuticals (INFIQ) | 0.3 | $1.1M | 133k | 8.24 | |
| Exelixis (EXEL) | 0.3 | $1.0M | 295k | 3.54 | |
| Sunesis Pharmaceuticals | 0.3 | $974k | 147k | 6.61 | |
| Threshold Pharmaceuticals | 0.3 | $936k | 197k | 4.76 | |
| Volcano Corporation | 0.3 | $872k | 44k | 19.72 | |
| Myriad Genetics (MYGN) | 0.2 | $840k | 25k | 34.19 | |
| Bind Therapeutics | 0.2 | $718k | 60k | 11.97 | |
| Haemonetics Corporation (HAE) | 0.2 | $653k | 20k | 32.57 | |
| Sorrento Therapeutics (SRNEQ) | 0.2 | $630k | 49k | 12.82 | |
| Newlink Genetics Corporation | 0.2 | $557k | 20k | 28.41 | |
| Macrogenics (MGNX) | 0.2 | $557k | 20k | 27.85 | |
| Lexicon Pharmaceuticals | 0.1 | $510k | 295k | 1.73 | |
| Anthera Pharmaceutcls | 0.1 | $395k | 118k | 3.35 |
